These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6713622)

  • 41. Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis.
    Robertson JA; Salusky IB; Goodman WG; Norris KC; Coburn JW
    Ann Intern Med; 1989 Jul; 111(2):179-81. PubMed ID: 2742249
    [No Abstract]   [Full Text] [Related]  

  • 42. [Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
    Bournerias F; Monnier N; Dufier JL; Réveillaud RJ
    Nephrologie; 1987; 8(1):27-9. PubMed ID: 3587485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of aluminum by LAMMA spectrometry in plasma and in synovial liquids of patients on chronic dialysis.
    Muller JF; Gelot MA; Netter P; Kaufmann R
    Biomed Pharmacother; 1982; 36(8-9):380-3. PubMed ID: 7182020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recognition and management of aluminum intoxication in children.
    Tsuru N; Williams JL; Chan JC
    Int J Pediatr Nephrol; 1987; 8(3):177-86. PubMed ID: 3323095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
    Winney RJ; Cowie JF; Robson JS
    Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
    [No Abstract]   [Full Text] [Related]  

  • 46. [Toxic effect of aluminum in chronic renal failure].
    Głuszek J
    Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical and pathophysiologic changes in patients on chronic dialysis: the central nervous system.
    Kerr DN
    Adv Nephrol Necker Hosp; 1980; 9():109-32. PubMed ID: 6773310
    [No Abstract]   [Full Text] [Related]  

  • 48. [Bone disorders in children with chronic renal insufficiency exposed to high ingestion of aluminum].
    Gordillo-Paniagua G; Valencia-Mayoral P; Mercado L; Medina-Mercado M
    Bol Med Hosp Infant Mex; 1990 May; 47(5):336-41. PubMed ID: 2390188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum aluminum and continuous ambulatory peritoneal dialysis.
    Wolf A; Graf H; Pinggera WF; Stummvoll HK; Meisinger V
    Ann Intern Med; 1980 Jan; 92(1):130-1. PubMed ID: 7350863
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum and lymphocyte, aluminum and nickel in chronic renal failure.
    Wills MR; Brown CS; Bertholf RL; Ross R; Savory J
    Clin Chim Acta; 1985 Jan; 145(2):193-6. PubMed ID: 3971590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
    Charhon SA; Chavassieux P; Chapuy MC; Accominotti M; Traeger J; Meunier PJ
    Presse Med; 1986 Jan; 15(2):55-9. PubMed ID: 2935857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicological aspects of aluminum poisoning in clinical nephrology.
    de Wolff FA
    Clin Nephrol; 1985; 24 Suppl 1():S9-14. PubMed ID: 3842105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The toxicity of aluminum].
    Lafontaine A; Noirfalise A
    Rev Med Liege; 1991 Dec; 46(12):658-63. PubMed ID: 1767154
    [No Abstract]   [Full Text] [Related]  

  • 54. How can toxic elements be localized in histological sections by laser microprobe mass analysis (LAMMA)?
    Schmidt PF; Barckhaus RH
    Prog Histochem Cytochem; 1991; 23(1-4):342-54. PubMed ID: 1947161
    [No Abstract]   [Full Text] [Related]  

  • 55. Aluminum and renal osteodystrophy in chronic uremia.
    Berland Y; Grandvuillemin M; Charhon S; Olmer M
    Kidney Int Suppl; 1985 Dec; 17():S183-7. PubMed ID: 3867793
    [No Abstract]   [Full Text] [Related]  

  • 56. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB; Foley J; Nelson P; Goodman WG
    N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detoxification in hemosiderosis.
    Simon P
    Blood Purif; 1985; 3(1-3):75-88. PubMed ID: 3913449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].
    Wang G; Zhu P; Wang S
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):36-40. PubMed ID: 9275645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deferoxamine for aluminum toxicity in dialysis patients.
    Hernandez P; Johnson CA
    ANNA J; 1990 Jun; 17(3):224-8. PubMed ID: 2357118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased body aluminum. An independent risk factor in patients undergoing long-term hemodialysis?
    Chazan JA; Blonsky SL; Abuelo JG; Pezzullo JC
    Arch Intern Med; 1988 Aug; 148(8):1817-20. PubMed ID: 3401104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.